March 3, 2026BMJ1 citations

India has overtaken the US on clinical trials but struggles with regulation

Key Points

India overtook the US in clinical trials due to its large patient population and infrastructure advancements.
Concerns arise over unethical practices in the expanding clinical trial sector, affecting credibility and safety.
A growing healthcare infrastructure plays a crucial role in attracting global clinical trials despite regulatory issues.
Regulatory frameworks may need enhancement to ensure ethical standards in India's clinical trial landscape.

Abstract

India’s vast patient population and growing healthcare infrastructure has seen it overtake the US as a go-to for clinical trials. But unethical practices worry doctors as the sector expands, writes Neha Bhatt

Ask AI

Helpful

Bookmark

View Full Paper

Cite This Study

Neha Bhatt (Fri,) studied this question.

synapsesocial.com/papers/69a76101c6e9836116a2e7e4 https://doi.org/https://doi.org/10.1136/bmj.s219

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

Ask AI

Helpful

Bookmark

View Full Paper